Health ❯ Pharmaceuticals ❯ Drug Approval Process

FDA Regulations

New Drug Application Clinical Trials Psychedelic Drugs Applied Therapeutics New Drug Applications

Cytokinetics Faces Wave of Investor Lawsuits as Lead Plaintiff Deadline Nears

Plaintiffs allege Cytokinetics overstated its aficamten approval timeline by submitting an NDA without a REMS after FDA safety discussions.

Cytokinetics Investors Urged to Act as Lead‑Plaintiff Deadline Nears in REMS‑Related Securities Suit

Investor Firms Urge Cytokinetics Shareholders to Seek Lead Role in FDA-Disclosure Suit Before Nov. 17